Detalhe da pesquisa
1.
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.
J Allergy Clin Immunol
; 152(4): 984-996.e10, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37390899
2.
Therapeutic options for CTLA-4 insufficiency.
J Allergy Clin Immunol
; 149(2): 736-746, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34111452
3.
What did we learn from CTLA-4 insufficiency on the human immune system?
Immunol Rev
; 287(1): 33-49, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30565239
4.
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.
J Allergy Clin Immunol
; 142(6): 1932-1946, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29729943
5.
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.
J Allergy Clin Immunol
; 139(3): 1043-1046.e5, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27908448
6.
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers.
Front Immunol
; 9: 2012, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30250467